JP2021105029A5 - - Google Patents

Download PDF

Info

Publication number
JP2021105029A5
JP2021105029A5 JP2021062805A JP2021062805A JP2021105029A5 JP 2021105029 A5 JP2021105029 A5 JP 2021105029A5 JP 2021062805 A JP2021062805 A JP 2021062805A JP 2021062805 A JP2021062805 A JP 2021062805A JP 2021105029 A5 JP2021105029 A5 JP 2021105029A5
Authority
JP
Japan
Prior art keywords
compound
galactopyranoside
fluorophenyl
triazole
bis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021062805A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021105029A (ja
Filing date
Publication date
Priority claimed from JP2018528313A external-priority patent/JP6863984B2/ja
Application filed filed Critical
Publication of JP2021105029A publication Critical patent/JP2021105029A/ja
Priority to JP2021142305A priority Critical patent/JP7254130B2/ja
Publication of JP2021105029A5 publication Critical patent/JP2021105029A5/ja
Pending legal-status Critical Current

Links

JP2021062805A 2015-12-18 2021-04-01 結晶多形とプロセス Pending JP2021105029A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2021142305A JP7254130B2 (ja) 2015-12-18 2021-09-01 結晶多形および医薬組成物

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP15201223 2015-12-18
EP15201223.3 2015-12-18
JP2018528313A JP6863984B2 (ja) 2015-12-18 2016-12-16 結晶多形とプロセス

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2018528313A Division JP6863984B2 (ja) 2015-12-18 2016-12-16 結晶多形とプロセス

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2021142305A Division JP7254130B2 (ja) 2015-12-18 2021-09-01 結晶多形および医薬組成物

Publications (2)

Publication Number Publication Date
JP2021105029A JP2021105029A (ja) 2021-07-26
JP2021105029A5 true JP2021105029A5 (cg-RX-API-DMAC10.html) 2021-10-14

Family

ID=54979474

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2018528313A Expired - Fee Related JP6863984B2 (ja) 2015-12-18 2016-12-16 結晶多形とプロセス
JP2021062805A Pending JP2021105029A (ja) 2015-12-18 2021-04-01 結晶多形とプロセス
JP2021142305A Active JP7254130B2 (ja) 2015-12-18 2021-09-01 結晶多形および医薬組成物

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2018528313A Expired - Fee Related JP6863984B2 (ja) 2015-12-18 2016-12-16 結晶多形とプロセス

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2021142305A Active JP7254130B2 (ja) 2015-12-18 2021-09-01 結晶多形および医薬組成物

Country Status (7)

Country Link
US (3) US10369136B2 (cg-RX-API-DMAC10.html)
EP (2) EP3390423B1 (cg-RX-API-DMAC10.html)
JP (3) JP6863984B2 (cg-RX-API-DMAC10.html)
CN (1) CN108602847A (cg-RX-API-DMAC10.html)
CA (1) CA3004632A1 (cg-RX-API-DMAC10.html)
ES (1) ES2925864T3 (cg-RX-API-DMAC10.html)
WO (1) WO2017103109A1 (cg-RX-API-DMAC10.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9243021B2 (en) * 2012-10-31 2016-01-26 Galecto Biotech Ab Galactoside inhibitor of galectins

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9027234D0 (en) 1990-12-15 1991-02-06 Harris Pharma Ltd An inhalation device
ES2141108T3 (es) 1991-07-02 2000-03-16 Inhale Inc Metodo y dispositivo para proporcionar medicamentos en aerosol.
CN1213974A (zh) 1996-01-03 1999-04-14 葛兰素集团有限公司 吸入器具
US6962151B1 (en) 1999-11-05 2005-11-08 Pari GmbH Spezialisten für effektive Inhalation Inhalation nebulizer
US6482847B2 (en) * 2000-10-03 2002-11-19 Hoffmann-La Roche Inc. Amorphous form of cell cycle inhibitor having improved solubility and bioavailability
DE10102846B4 (de) 2001-01-23 2012-04-12 Pari Pharma Gmbh Aerosolgenerator
ATE269735T1 (de) 2001-10-18 2004-07-15 Pari Gmbh Inhalationstherapievorrichtung
ATE463304T1 (de) 2002-08-02 2010-04-15 Pari Pharma Gmbh Vorrichtung zur erzeugung von flüssigkeitströpfchen
DE10250625A1 (de) 2002-10-30 2004-05-19 Pari GmbH Spezialisten für effektive Inhalation Inhalationstherapievorrichtung
DE10257381B4 (de) 2002-12-09 2006-09-14 Pari GmbH Spezialisten für effektive Inhalation Inhalationstherapievorrichtung
PT104350A (pt) * 2009-01-23 2010-07-23 Hovione Farmaci Ncia S A Processo de isolamento de tigeciclina
DE102009026636B4 (de) 2009-06-02 2011-04-14 Pari Pharma Gmbh Verfahren zum Verschweißen einer Membran mit einem Träger bei der Herstellung eines Membranverneblers
US9243021B2 (en) 2012-10-31 2016-01-26 Galecto Biotech Ab Galactoside inhibitor of galectins
IN2015DN02573A (cg-RX-API-DMAC10.html) * 2012-10-31 2015-09-11 Galecto Biotech Ab
EP2919802A4 (en) * 2012-11-15 2016-09-14 Univ Tufts METHOD, COMPOSITIONS AND KITS FOR TREATING, MODULATING OR PREVENTING ANGIOGENESIS OR FIBROSIS IN A PATIENT USING A GALECTINE PROTEIN HEMMER
US20170095496A1 (en) * 2014-04-08 2017-04-06 Galecto Biotech Ab Galactoside inhibitors for new uses

Similar Documents

Publication Publication Date Title
US20220218683A1 (en) Aerosol pirfenidone and pyridone analog compounds and uses thereof
PT2506844T (pt) Combinações de um antagonista do recetor muscarínico e um agonista do adrenorrecetor beta-2
CA2871358A1 (en) Novel dosage form and formulation of abediterol
CN106488770A (zh) 用于治疗copd的福莫特罗和布地奈德的组合
US20110166149A1 (en) Pteridine derivatives for treating respiratory disease
JP7254130B2 (ja) 結晶多形および医薬組成物
JP2010538081A (ja) Dheas吸入組成物
WO2014037727A1 (en) Carcainium salts
JP6908523B2 (ja) ネブライザー用組成物
HK1232787A1 (en) Combinations of formoterol and budesonide for the treatment of copd